4.7 Review

Phospholipases in Gliomas: Current Knowledge and Future Perspectives from Bench to Bedside

Journal

BIOMOLECULES
Volume 13, Issue 5, Pages -

Publisher

MDPI
DOI: 10.3390/biom13050798

Keywords

phospholipases; brain tumors; gliomas; therapeutic target; prognostic biomarker

Ask authors/readers for more resources

Phospholipases are crucial enzymes that hydrolyze phospholipids, the most abundant species in the biological membranes of healthy human brain cells. They generate lipid mediators that play essential roles in intra- and inter-cellular signaling, regulating various cellular mechanisms involved in tumor progression and aggressiveness.
Phospholipases are essential intermediaries that work as hydrolyzing enzymes of phospholipids (PLs), which represent the most abundant species contributing to the biological membranes of nervous cells of the healthy human brain. They generate different lipid mediators, such as diacylglycerol, phosphatidic acid, lysophosphatidic acid, and arachidonic acid, representing key elements of intra- and inter-cellular signaling and being involved in the regulation of several cellular mechanisms that can promote tumor progression and aggressiveness. In this review, it is summarized the current knowledge about the role of phospholipases in brain tumor progression, focusing on low- and high-grade gliomas, representing promising prognostic or therapeutic targets in cancer therapies due to their influential roles in cell proliferation, migration, growth, and survival. A deeper understanding of the phospholipases-related signaling pathways could be necessary to pave the way for new targeted therapeutic strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available